HK1029914A1 - Device and pharmaceutical agent for treatment of dysmenorrhea - Google Patents

Device and pharmaceutical agent for treatment of dysmenorrhea

Info

Publication number
HK1029914A1
HK1029914A1 HK01100962A HK01100962A HK1029914A1 HK 1029914 A1 HK1029914 A1 HK 1029914A1 HK 01100962 A HK01100962 A HK 01100962A HK 01100962 A HK01100962 A HK 01100962A HK 1029914 A1 HK1029914 A1 HK 1029914A1
Authority
HK
Hong Kong
Prior art keywords
dysmenorrhea
treatment
pharmaceutical agent
pharmaceutical
agent
Prior art date
Application number
HK01100962A
Other languages
English (en)
Inventor
Donald C Harrison
James H Liu
Wolfgang A Ritschel
Roger A Stern
Original Assignee
Umd Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26727068&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1029914(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Umd Inc filed Critical Umd Inc
Publication of HK1029914A1 publication Critical patent/HK1029914A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
HK01100962A 1997-06-11 2001-02-09 Device and pharmaceutical agent for treatment of dysmenorrhea HK1029914A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4932597P 1997-06-11 1997-06-11
US09/079,897 US6197327B1 (en) 1997-06-11 1998-05-15 Device and method for treatment of dysmenorrhea
PCT/US1998/010785 WO1998056323A1 (fr) 1997-06-11 1998-06-10 Dispositif et procede de traitement de la dysmenorrhee

Publications (1)

Publication Number Publication Date
HK1029914A1 true HK1029914A1 (en) 2001-04-20

Family

ID=26727068

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01100962A HK1029914A1 (en) 1997-06-11 2001-02-09 Device and pharmaceutical agent for treatment of dysmenorrhea

Country Status (11)

Country Link
US (2) US6197327B1 (fr)
EP (1) EP0988009A4 (fr)
JP (1) JP2002515069A (fr)
CN (1) CN1199621C (fr)
AU (1) AU735407B2 (fr)
BR (1) BR9810089A (fr)
CA (1) CA2293346C (fr)
HK (1) HK1029914A1 (fr)
IL (2) IL133431A0 (fr)
NZ (1) NZ502120A (fr)
WO (1) WO1998056323A1 (fr)

Families Citing this family (159)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183497B1 (en) * 1998-05-01 2001-02-06 Sub-Q, Inc. Absorbable sponge with contrasting agent
US6071300A (en) * 1995-09-15 2000-06-06 Sub-Q Inc. Apparatus and method for percutaneous sealing of blood vessel punctures
EP1158978B1 (fr) * 1997-02-15 2005-10-05 Edelstam Inc. Medicament contre la dysmenorrhee et le syndrome premenstruel contenant lidocaine
US20040043071A1 (en) * 2002-06-21 2004-03-04 Pauletti Giovanni M. Intravaginal mucosal or transmucosal delivery of antimigraine and antinausea drugs
US7744916B2 (en) * 1997-06-11 2010-06-29 Umd, Inc. Coated vaginal device for delivery of anti-migraine and anti-nausea drugs
US6572874B1 (en) * 1998-05-15 2003-06-03 Umd, Inc. Vaginal delivery of bisphosphonates
US6905701B2 (en) * 1997-06-11 2005-06-14 Umd, Inc. Formulations for transmucosal vaginal delivery of bisphosphonates
US20050276836A1 (en) * 1997-06-11 2005-12-15 Michelle Wilson Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
EP1356806A1 (fr) * 1997-09-12 2003-10-29 Columbia Laboratories (Bermuda) Limited Composition pharmaceutique destinée au traitement des dysmenorrhées et de l'accouchement prématuré
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
DE69819748T2 (de) 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US20010045575A1 (en) * 1998-05-01 2001-11-29 Mark Ashby Device and method for facilitating hemostasis of a biopsy tract
US6315753B1 (en) * 1998-05-01 2001-11-13 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US20050255039A1 (en) * 1998-06-26 2005-11-17 Pro Surg, Inc., A California Corporation Gel injection treatment of breast, fibroids & endometrial ablation
US6264973B1 (en) * 1999-08-26 2001-07-24 Fei Enterprises, Ltd. Apparatus and method for anesthetizing the cervical region of a female
US6984219B2 (en) * 1999-09-23 2006-01-10 Mark Ashby Depth and puncture control for blood vessel hemostasis system
RU2310474C2 (ru) * 1999-10-05 2007-11-20 Колумбия Лабораториз (Бермуда) Лимитед Способ лечения эндометриоза или бесплодия или улучшение способности к воспроизведению потомства и фармацевтическая композиция для его осуществления
GB0009914D0 (en) 2000-04-20 2000-06-07 Metris Therapeutics Limited Device
IL138183A0 (en) * 2000-08-31 2001-10-31 Rostam Ltd Ph reducing formulation and delivery system for a tampon
US6503190B1 (en) 2000-09-29 2003-01-07 Ethicon Endo-Surgery, Inc. Vaginal pessary
CA2436570A1 (fr) * 2000-12-06 2002-06-13 Pharmacia Corporation Composition pharmaceutique a dispersion rapide
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US8187625B2 (en) 2001-03-12 2012-05-29 Boston Scientific Scimed, Inc. Cross-linked gelatin composition comprising a wetting agent
US20030004143A1 (en) * 2001-04-18 2003-01-02 Prior Christopher P. Use of NSAIDs for prevention and treatment of cellular abnormalities of the female reproductive tract
US7008440B2 (en) * 2001-11-08 2006-03-07 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
WO2003007862A2 (fr) * 2001-07-19 2003-01-30 Peter James Brian Lamb Tampon
US6899700B2 (en) 2001-08-29 2005-05-31 Kimberly-Clark Worldwide, Inc. Therapeutic agent delivery tampon
AU2002329842B2 (en) * 2001-08-29 2006-09-14 Umd, Inc. Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en) * 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
ATE371454T1 (de) * 2001-10-31 2007-09-15 Medical Res Council Antagonisten der prostaglandin ep2 und/oder ep4 rezeptoren zur behandlung von menorrhagie
JP2005519873A (ja) * 2001-11-14 2005-07-07 アルザ・コーポレーション カテーテル注入可能なデポー組成物およびそれらの使用
WO2003041684A2 (fr) * 2001-11-14 2003-05-22 Alza Corporation Compositions en depot injectables et utilisations
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
WO2003051227A2 (fr) * 2001-12-14 2003-06-26 Syed Rizvi Lingette hygienique utile dans le traitement symptomatique de la vaginite
US6888043B2 (en) 2001-12-21 2005-05-03 Kimberly-Clark Worldwide, Inc. Feminine care products for the delivery of therapeutic substances
US20030120225A1 (en) * 2001-12-21 2003-06-26 Kimberly-Clark Worldwide, Inc. Therapeutic agent delivery labial pad
JP4663237B2 (ja) * 2002-02-24 2011-04-06 ハイ−ジェニック イントラ−バージナル テクノロジーズ エルティーディー 月経用タンポン
US7004171B2 (en) * 2002-02-25 2006-02-28 Hi-Gienic Intra Vaginal Technologies Ltd. System for transvaginal drug delivery
EP1494715A1 (fr) * 2002-04-17 2005-01-12 Medical Research Council Antagonistes du recepteur fp ou antagonistes de pgf2 alpha destines au traitement de la menorragie
GB0208785D0 (en) * 2002-04-17 2002-05-29 Medical Res Council Treatment methtods
ITMI20021078A1 (it) * 2002-05-21 2003-11-21 Technipharma Llc Uso di sistemi topici transdermali per la prevenzione e cura della dismenorrea primaria
MXPA04011584A (es) * 2002-05-23 2005-03-31 Umd Inc Composiciones y metodo para la administracion y crioproteccion de drogas transmucosales.
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US8252303B2 (en) * 2002-07-31 2012-08-28 Durect Corporation Injectable depot compositions and uses thereof
CN1684663A (zh) * 2002-07-31 2005-10-19 阿尔萨公司 可注射的多模式聚合物储库组合物以及其用途
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
JP2006512409A (ja) * 2002-10-31 2006-04-13 ユーエムディー， インコーポレイテッド 薬物送達用治療組成物で被覆上皮に対するもの及びそれを介するもの
US7455680B1 (en) * 2002-11-04 2008-11-25 Boston Scientific Scimed, Inc. Apparatus and method for inhibiting blood loss
US20060171945A1 (en) * 2003-02-14 2006-08-03 Critchley Hilary Octavia D Ip receptor antagonists for the treatment of pathological uterine conditions
US20040209850A1 (en) * 2003-04-15 2004-10-21 Theraquest Biosciences, Llc Methods of treating pain and compositions for use therefor
DE602004026173D1 (de) 2003-04-29 2010-05-06 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
US8404272B2 (en) * 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
US8399013B2 (en) * 2003-06-26 2013-03-19 Poly-Med, Inc. Partially absorbable fiber-reinforced composites for controlled drug delivery
EP1686935A4 (fr) * 2003-10-22 2009-06-17 Univ Cleveland Hospitals Procede et appareil pour appliquer des medicaments a un tissu interne
US7875043B1 (en) 2003-12-09 2011-01-25 Sub-Q, Inc. Cinching loop
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
US8217219B2 (en) 2003-12-29 2012-07-10 Kimberly-Clark Worldwide, Inc. Anatomically conforming vaginal insert
AU2005212123A1 (en) * 2004-02-18 2005-08-25 Mercian Corporation Method of preventing, medicating and/or treating hypocalcaemia of domestic mammal
US7892218B2 (en) * 2004-03-03 2011-02-22 Rostam Ltd. pH reducing formulation
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
TR201802446T4 (tr) * 2004-05-19 2018-03-21 Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct Sodyum deoksikolat içeren enjeksiyonluk bileşim.
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
US20060100566A1 (en) * 2004-11-05 2006-05-11 Women's Medical Research Group, Llc Apparatus and method for the treatment of dysmenorrhea
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
US7527614B2 (en) * 2005-03-25 2009-05-05 Kimberly-Clark Worldwide, Inc. Protective tube for a medicated tampon
US7993667B2 (en) 2005-03-25 2011-08-09 Kimberly-Clark Worldwide, Inc. Methods of manufacturing a medicated tampon assembly
US7744556B2 (en) * 2005-03-25 2010-06-29 Kimberly-Clark Worldwide, Inc. Delivery tube assembly for an applicator
US7919453B2 (en) * 2005-03-25 2011-04-05 Kimberly-Clark Worldwide, Inc. Dosage cap assembly for an applicator
US9295289B2 (en) * 2005-04-01 2016-03-29 Leslie Jane James Waist-fastening, hip-encompassing apparel with at least one concealed storage compartment
US7708726B2 (en) * 2005-04-28 2010-05-04 Kimberly-Clark Worldwide, Inc. Dosage form cap for an applicator
WO2006133048A2 (fr) * 2005-06-03 2006-12-14 Duramed Pharmaceuticals, Inc. Compositions pharmaceutiques comprenant des agonistes des recepteurs prostanoides et procedes de fabrication et d'utilisation de celles-ci
US20070016156A1 (en) * 2005-07-15 2007-01-18 The Procter & Gamble Company Absorbent tampon comprising a visually distinct withdrawal member
CA2618349C (fr) 2005-08-11 2016-05-31 Massachusetts Institute Of Technology Dispositif et procede d'administration de medicament par voie intravesicale
US20070141118A1 (en) * 2005-12-15 2007-06-21 Damico Joyce A Layered dosage form for a medicated tampon assembly
US20070156077A1 (en) * 2005-12-30 2007-07-05 Pfister Margaret M Personal hygiene system and methods
CN101448452B (zh) * 2006-03-20 2012-07-18 特卫华妇女健康有限公司 挠性压缩的阴道内环、其制备和使用方法及其生产设备
US8399012B2 (en) * 2006-04-17 2013-03-19 Kimberly-Clark Worldwide, Inc. Degradable therapeutic delivery device
US8137327B2 (en) * 2006-06-16 2012-03-20 Family Health International Vaginal drug delivery system and method
GB0613333D0 (en) * 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) * 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
MX2009000053A (es) * 2006-07-12 2009-02-23 Controlled Therapeutics Sct Polimero para el suministro de medicamentos con sal clorhidrato de clindamicina.
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
US20080193385A1 (en) * 2007-02-08 2008-08-14 Todd Maibach Compositions and methods for treating neuropathy
WO2009073782A2 (fr) * 2007-12-04 2009-06-11 Ams Research Corporation Appareil et procédés de traitement d'états prolifératifs pathologiques du tissu utérin
ES2481454T3 (es) * 2007-12-11 2014-07-30 Massachusetts Institute Of Technology Dispositivo implantable de administración de fármacos
CA3016642A1 (fr) * 2008-02-04 2009-08-13 Ferring B.V. Bagues intravaginales monolithiques renfermant de la progesterone et methodes de fabrication et utilisations associees
WO2009130265A2 (fr) * 2008-04-23 2009-10-29 Andreas Grundlehner Dispositif médical
US9034365B2 (en) 2008-05-20 2015-05-19 Poly-Med, Inc. Biostable, multipurpose, microbicidal intravaginal devices
EP2328628A2 (fr) 2008-08-09 2011-06-08 Massachusetts Institute of Technology Dispositif implantable d'administration de médicaments et procédés de traitement de tissus génito-urinaires mâles et environnants
US20100087402A1 (en) * 2008-09-29 2010-04-08 Vivus, Inc. Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders
CN102283827A (zh) * 2008-10-16 2011-12-21 四川维信医药科技有限责任公司 单硝酸异山梨酯的新用途
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
CA3031836A1 (fr) 2009-05-05 2010-11-11 Board Of Regents, The University Of Texas System Formulations d'anesthesiques volatils pour reduire l'inflammation
CA2766197C (fr) 2009-06-23 2017-07-25 Bernhard Lindenthal Composition pharmaceutique pour contraception d'urgence
EP2445571B1 (fr) * 2009-06-26 2012-11-21 Taris Biomedical, Inc. Comprimés de médicament solides pour dispositifs d'administration de médicament implantables
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US8882748B2 (en) * 2009-10-08 2014-11-11 Palo Alto Research Center Incorporated Transmucosal drug delivery device and method including chemical permeation enhancers
US9017310B2 (en) * 2009-10-08 2015-04-28 Palo Alto Research Center Incorporated Transmucosal drug delivery device and method including microneedles
US9014799B2 (en) * 2009-10-08 2015-04-21 Palo Alto Research Center Incorporated Transmucosal drug delivery device and method including electrically-actuated permeation enhancement
IT1397000B1 (it) * 2009-11-12 2012-12-20 Antropoli Uso di un preparato basato sulla nifedipina per il trattamento del vaginismo
US20120035265A1 (en) * 2010-03-08 2012-02-09 Medicinova, Inc. Compositions, methods, and devices for the treatment of dysmenorrhea
CA2793712A1 (fr) * 2010-03-22 2011-09-29 Repros Therapeutics Inc. Compositions et procedes pour l'apport non toxique d'antiprogestines
ES2822118T3 (es) 2010-08-05 2021-04-29 Taris Biomedical Llc Dispositivos de administración de fármacos implantables para sitios genitourinarios
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
BR112013011744B1 (pt) 2010-11-12 2021-04-27 The University Of Utah Research Foundation Dispositivo intravaginal para distribuição controlada de lubrificantes
WO2012092990A2 (fr) 2011-01-05 2012-07-12 Udo Wenske Produit médical pour l'amélioration de la fertilité d'un mammifère
RU2620032C2 (ru) 2011-01-10 2017-05-22 Аллерган, Инк. Схема приема лидокаина для применения в продолжительном лечении боли в мочевом пузыре и раздражения при мочеиспускании
AU2011200392B2 (en) * 2011-01-31 2015-05-28 Palo Alto Research Center Incorporated Transmucosal drug delivery device
US9107816B2 (en) 2011-02-04 2015-08-18 Taris Biomedical Llc Implantable device for controlled dissolution and diffusion of low solubility drug
WO2012112940A1 (fr) 2011-02-18 2012-08-23 Kythera Biopharmaceuticals, Inc. Traitement de graisse sous-mentale
DE202011110360U1 (de) * 2011-03-02 2014-01-15 Arstat, Inc. Artikel für die weibliche Hygiene mit antifibrinolytischem oder hämostatischem Wirkstoff und pharmazeutische Zusammensetzung
WO2012121811A1 (fr) * 2011-03-04 2012-09-13 Arstat, Inc. Traitement des pertes de sang menstruelles excessives par administration intravaginale de faibles doses d'un agent antifibrinolytique ou hémostatique
US8476221B2 (en) 2011-03-18 2013-07-02 Halimed Pharmaceuticals, Inc. Methods and compositions for the treatment of metabolic disorders
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
DE202012012761U1 (de) 2011-04-07 2013-10-29 Arstat, Inc. Mit Arzneimittel versehene intravaginale Vorrichtung und pharmazeutische Zusammensetzung zur Behandlung von Menstruationsschmerzen und übermäßigem Menstruationsblutverlust
WO2013029194A1 (fr) * 2011-08-26 2013-03-07 Universidad De Santiago De Chile Utilisation des anti-inflammatoires non stéroïdiens meloxicam et piroxicam, par voie intravaginale, à des fins d'interruption du processus d'ovulation chez la femme
WO2013036447A1 (fr) 2011-09-09 2013-03-14 Gyneconcepts, Inc. Dispositif d'auto-échantillonnage de tissu de cellules cervicales
JP5902318B2 (ja) * 2011-12-29 2016-04-13 ラボラトリオス アンドロマコ ソシエダッド アノニマ メロキシカム、および有効成分の放出を調節する薬剤を含み、女性における連続使用避妊に用いられることができる膣リング
CN102793659B (zh) * 2012-08-15 2013-09-04 蚌埠丰原涂山制药有限公司 一种阿司匹林栓剂及其制备方法
US9005108B2 (en) 2012-09-27 2015-04-14 Palo Alto Research Center Incorporated Multiple reservoir drug delivery device and methods
US9999720B2 (en) 2012-09-27 2018-06-19 Palo Alto Research Center Incorporated Drug reconstitution and delivery device and methods
US9744341B2 (en) 2013-01-15 2017-08-29 Palo Alto Research Center Incorporated Devices and methods for intraluminal retention and drug delivery
US9775864B2 (en) 2013-01-31 2017-10-03 Ams Research Corporation Vaginal laxity therapy utilizing cell-based bulking compositions
AU2014214537B2 (en) * 2013-02-06 2019-01-03 Mark SILLENDER Therapeutic substance transfer catheter and method
DK2964088T3 (da) * 2013-03-08 2023-06-06 Li Galli B V I O Vaginalt lægemiddeladministrations- og/eller diagnosesystem
SG10201708522SA (en) 2013-03-15 2017-12-28 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
EP3033087A4 (fr) 2013-08-16 2017-03-15 The J. David Gladstone Institutes Compositions et procédés permettant d'identifier des cellules infectées de manière latente.
ES2956840T3 (es) 2013-08-19 2023-12-29 Taris Biomedical Llc Dispositivos de administración de fármacos de múltiples unidades
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
WO2015088990A1 (fr) 2013-12-09 2015-06-18 Durect Corporation Complexes de principes pharmaceutiquement actifs, complexes de polymères, et compositions et procédés les impliquant
US9297083B2 (en) 2013-12-16 2016-03-29 Palo Alto Research Center Incorporated Electrolytic gas generating devices, actuators, and methods
US9801660B2 (en) 2014-07-31 2017-10-31 Palo Alto Research Center Incorporated Implantable fluid delivery devices, systems, and methods
US10278675B2 (en) 2014-07-31 2019-05-07 Palo Alto Research Center Incorporated Implantable estrus detection devices, systems, and methods
WO2016061131A1 (fr) 2014-10-14 2016-04-21 The J. David Gladstone Institutes Compositions et procédés pour réactiver un virus d'immunodéficience latent
WO2016112388A1 (fr) * 2015-01-10 2016-07-14 Nine Medical, Inc. Méthodes et dispositifs visant à prévenir les naissances prématurées
MA41629A (fr) 2015-03-04 2018-01-09 Center For Human Reproduction Compositions et méthodes d'utilisation de l'hormone anti-müllérienne pour le traitement de l'infertilité
WO2016172704A1 (fr) 2015-04-23 2016-10-27 Taris Biomedical Llc Dispositifs d'administration de médicaments dotés d'un composant perméable aux médicaments et procédés associés
EP3272333A1 (fr) 2016-07-22 2018-01-24 Chemo Research, S.L. Composition vaginale comprenant une combinaison d'oestrogène et de vitamine d
WO2018026764A1 (fr) 2016-08-01 2018-02-08 University Of Rochester Nanoparticules pour la libération contrôlée d'agents anti-biofilm et procédés d'utilisation
AU201617347S (en) * 2016-12-23 2017-01-23 Jurox Pty Ltd intravaginal device
WO2020041333A1 (fr) 2018-08-22 2020-02-27 The J. David Gladstone Institutes Méthodes de traitement de la cardiopathie valvulaire
CA3114750A1 (fr) 2018-10-09 2020-04-16 University Of Rochester Traitement de troubles vulvovaginaux
US11382799B2 (en) 2018-11-26 2022-07-12 Bluegrass Farmaceuticals, LLC Tampon with intravaginal cannabinoid delivery device
WO2020247756A1 (fr) * 2019-06-05 2020-12-10 Forcyte Biotechnologies, Inc. Petites molécules pour relaxer les contractions des muscules lisses de l'utérus
EP3982996A1 (fr) 2019-06-14 2022-04-20 The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone Compositions et méthodes de traitement d'une infection par le virus de l'immunodéficience à l'aide d'une particule interférente thérapeutique
US11872395B2 (en) * 2019-06-18 2024-01-16 Obstetric Solutions, Llc Pessary device and methods for preventing premature births
US12011602B2 (en) 2019-06-18 2024-06-18 Obstetric Solutions Llc Wireless power for pessary device
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
KR102159904B1 (ko) 2020-04-24 2020-09-24 강경원 약물 방출 고리를 구비한 월경컵
CA3202468A1 (fr) 2021-01-14 2022-07-21 Paul Buss Systeme d'administration d'un composant pharmaceutique, holistique ou medicinal
CN112915063B (zh) * 2021-01-25 2022-12-20 刘红枚 一种用于治疗子宫平滑肌高频率强直性收缩相关疾病的化合物

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE586891A (fr) * 1959-01-26 1960-05-16 Jerome Y Lettvin Tampon cataménial perfectionné.
US3852155A (en) * 1971-09-02 1974-12-03 R Moore Cryopreservation of equine cell cultures
US3884233A (en) 1973-09-04 1975-05-20 Betty Louise Summey Tampon and suppository combination
US3902493A (en) 1974-05-13 1975-09-02 Procter & Gamble Medicated catamenial tampon
US4073743A (en) * 1975-04-17 1978-02-14 Merck & Co., Inc. Process for preparing an emulsion
US4016270A (en) * 1975-10-31 1977-04-05 Alza Corporation Method for treating dysmenorrhea with a uterine therapeutic system
US4082881A (en) 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
US4200101A (en) 1977-04-11 1980-04-29 Glassman Jacob A Catamenial tampon
US4250166A (en) * 1977-05-27 1981-02-10 Shionogi & Co., Ltd. Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
US4271835A (en) 1978-05-17 1981-06-09 Kcdp Corporation Fluid-expansible contraceptive tampon and applicator
US4309997A (en) 1978-06-09 1982-01-12 Donald Jack W Contraceptive and/or antivenereal disease tampon
US4756907A (en) 1978-10-17 1988-07-12 Stolle Research & Development Corp. Active/passive immunization of the internal female reproductive organs
US4292965A (en) 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4317447A (en) 1979-07-19 1982-03-02 Ortho Pharmaceutical Corporation Drug delivery system
US4383993A (en) 1980-05-30 1983-05-17 University Of Kentucky Research Foundation Nasal dosage forms containing natural female sex hormones
US4318405A (en) 1980-07-24 1982-03-09 Sneider Vincent R Tampon and drug delivery device
US4405323A (en) 1981-09-08 1983-09-20 Sidney Auerbach Sanitary napkin
US4863725A (en) * 1982-10-27 1989-09-05 Deckner George E Novel clear oil-free moisturizer composition
US4540581A (en) 1984-01-31 1985-09-10 Bristol-Myers Company Topical nonsteroidal anti-inflammatory compositions and uses
US4780480A (en) 1983-07-14 1988-10-25 Syntex (U.S.A.) Inc. Aroyl benzofuran and benzothiophene acetic and propionic acids
US4560549A (en) * 1983-08-24 1985-12-24 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
ATE151286T1 (de) * 1983-11-14 1997-04-15 Columbia Lab Inc Bioadhäsive mittel
US4983392A (en) * 1983-11-14 1991-01-08 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
JPS6160620A (ja) 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
JP2519029B2 (ja) * 1985-10-31 1996-07-31 ケ−・ブイ・ファ−マシュ−ティカル・カンパニ− 腟内送達用製剤
EP0283085B1 (fr) * 1987-03-17 1992-11-11 Akzo N.V. Mélange adjuvant
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
CA1341245C (fr) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Virus recombinant de la vaccine derive du virus modifie ankara
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
IT1230157B (it) * 1989-06-16 1991-10-14 Lisapharma Spa Uso di sucralfato gel umido per il trattamento di ulcere del derma e come veicolo di farmaci ad attivita' topica
DE3928677C2 (de) 1989-08-30 1998-05-14 Kimberly Clark Gmbh Tampon für medizinische oder hygienische Zwecke sowie Verfahren zu seiner Herstellung
US5295984A (en) 1989-12-07 1994-03-22 Ultrafem, Inc. Vaginal discharge collection device and intravaginal drug delivery system
US5651973A (en) 1990-06-01 1997-07-29 The Population Council Therapeutically effective topical application of ST1435
FR2665357B1 (fr) * 1990-07-31 1995-03-31 Aiache Jean Marc Procede de preparation d'une forme galenique bio-adhesive et forme galenique ainsi preparee.
US5275820A (en) * 1990-12-27 1994-01-04 Allergan, Inc. Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles
JPH0767716B2 (ja) * 1991-01-14 1995-07-26 新日鐵化学株式会社 熱可塑性樹脂成形品の射出成形法及び射出成形用金型
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
DE4138100A1 (de) 1991-11-19 1993-05-27 Wisap Gmbh Adhaesionsprophylaxe
US5393528A (en) 1992-05-07 1995-02-28 Staab; Robert J. Dissolvable device for contraception or delivery of medication
US5273521A (en) 1992-08-26 1993-12-28 Peiler Frances K Tampon applicator for delivery of a medicament
ATE239431T1 (de) * 1992-10-21 2003-05-15 Gynetech Lab Inc Abgabesystem bestehend aus einem vaginaschwamm
US5330761A (en) * 1993-01-29 1994-07-19 Edward Mendell Co. Inc. Bioadhesive tablet for non-systemic use products
GB9522403D0 (en) * 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device

Also Published As

Publication number Publication date
CA2293346C (fr) 2008-10-21
AU7697698A (en) 1998-12-30
US6197327B1 (en) 2001-03-06
CN1199621C (zh) 2005-05-04
CN1263454A (zh) 2000-08-16
EP0988009A1 (fr) 2000-03-29
JP2002515069A (ja) 2002-05-21
US6086909A (en) 2000-07-11
IL133431A (en) 2008-12-29
IL133431A0 (en) 2001-04-30
CA2293346A1 (fr) 1998-12-17
EP0988009A4 (fr) 2006-04-19
AU735407B2 (en) 2001-07-05
NZ502120A (en) 2002-04-26
BR9810089A (pt) 2000-08-08
WO1998056323A1 (fr) 1998-12-17

Similar Documents

Publication Publication Date Title
HK1029914A1 (en) Device and pharmaceutical agent for treatment of dysmenorrhea
EP0996497A4 (fr) Dispositif et procede de traitement de liquide
EP0776215A4 (fr) Dispositif d'administration de substances et ses modes d'utilisation
IL132424A0 (en) Prescription compliance device and method of using the device
PL305701A1 (en) Pharmaceutical agent
HUP0004105A2 (en) Method and device for sewage treatment
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
EP1043043A4 (fr) Dispositif d'ionophorese et unite de medicament
AP9801173A0 (en) Rapidly releasing and taste-making pharmaceutical dosage
GB9812056D0 (en) Pharmaceutical composition for treatment of ibd and rbd
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
HUT77918A (hu) Berendezés és alkalmazása oxiklórozáshoz
GB9808840D0 (en) Treatment of depression and pharmaceutical preparations therefor
EP0983958A4 (fr) Escalier roulant et marche d'escalier roulant
GB9809448D0 (en) Treatment device and method
EP0987942A4 (fr) Composition pharmaceutique et procede d'utilisation
AU9337598A (en) Magnetically therapeutic treatment device
IL112681A0 (en) Opioid peptides for the treatment of pain and use thereof
AU8809098A (en) Procedure and apparatus for the treatment of waste
EP0925791A4 (fr) Agent preventif et/ou therapeutique pour les maladies des reins
GB9712707D0 (en) Medical device and use thereof
GB9717451D0 (en) Apparatus for treatment of surfaces
GB9704174D0 (en) Agent for medical treatment
GB9523066D0 (en) Compounds and their therapeutic use
AUPO732597A0 (en) Pharmaceutical agent and method of treatment

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100610